Lesion Detection and Volumetric Analysis Automation Workflow

This workflow automates the labor-intensive, error-prone process of manually contouring and measuring lesions across serial CT, MRI, or PET scans. By deploying specialized agents for detection, 3D segmentation, and growth calculation, it eliminates a critical bottleneck in oncology and clinical trial operations. The operational upside is direct: a 70-80% reduction in manual contouring time per case, standardized quantitative outputs that slash inter-reader variability, and accelerated time-to-decision for treatment response assessments in both clinical care and drug development.

Implementation requires tight integration with hospital PACS, RIS, and EHRs via HL7/FHIR, and clinical trial EDC systems. The orchestration layer, built with frameworks like LangGraph, manages specialized agents for DICOM preprocessing, ensemble model inference, and RECIST/WHO criteria calculation. Critical controls include a confidence-scoring engine to route uncertain segmentations for human review, comprehensive audit trails for all overrides, and continuous performance monitoring against gold-standard annotations to detect model drift and ensure regulatory-grade reliability in production.

This workflow automates the repetitive, high-variability manual task of contouring lesions and calculating volumetric change across serial CT, MRI, or PET scans. The operational upside comes from accelerating treatment response assessment by 70-80%, standardizing measurements to reduce inter-reader variability in clinical trials, and freeing radiologists from manual segmentation for higher-value diagnostic review. It directly impacts oncology throughput and trial endpoint accuracy.

Implementation integrates with hospital PACS and clinical trial EDC systems via DICOM and HL7/FHIR. The orchestration layer, built with LangGraph or a custom service, manages specialized agents for preprocessing, inference using ensemble models (e.g., nnU-Net), and 3D analysis. Critical controls include confidence scoring to route uncertain segmentations for human review, an immutable audit log of all overrides for regulatory compliance, and continuous performance monitoring against a gold-standard dataset to detect model drift. The final output feeds quantitative metrics directly into structured reports and longitudinal dashboards.

This workflow automates the repetitive, high-variability manual contouring and measurement of lesions across serial scans, a critical bottleneck in oncology and clinical trial imaging. The operational upside comes from reducing radiologist contouring time by 30-50% and standardizing volumetric measurements, which directly accelerates treatment response evaluation (e.g., RECIST criteria) and improves data consistency for trial endpoints. Implementation requires orchestration across PACS, specialized segmentation models, and a volumetric analytics engine, with strict controls for confidence scoring and human review.

Implementation integrates with hospital PACS/RIS via DICOM and HL7/FHIR, deploying containerized segmentation models (e.g., nnU-Net) on GPU clusters. The orchestrator, built with LangGraph, manages state, routes exceptions, and logs all overrides for audit. A key constraint is data quality; a preprocessing agent must validate scan protocols and correct artifacts. Rollout is sequenced, starting with a single modality and expanding, with continuous monitoring for model drift against a gold-standard annotation set to maintain diagnostic accuracy and regulatory compliance.

Governance begins with a phased deployment strategy, starting with a non-diagnostic shadow mode where AI-generated segmentations and volumes are logged but not displayed. This validates model performance against historical, physician-contoured ground truth across diverse patient demographics and scanner types. Concurrently, you establish a clinical steering committee to define escalation protocols for low-confidence results, major measurement discrepancies, and system downtime, integrating these rules directly into the orchestration layer using tools like LangGraph for stateful decision routing.

The rollout architecture must include immutable audit trails logging every AI inference, physician override, and final measurement. Integrate this with your PACS (e.g., Epic, Sectra) and clinical trial EDC systems to automate data flow. Monitoring dashboards should track key performance indicators: reduction in manual contouring time per case, inter-reader variability, and throughput gains in treatment response assessments. A formal change control process, managed through the orchestration platform, governs all model updates, ensuring retrained models are validated against a locked test set before promotion, maintaining continuous regulatory readiness for FDA 510(k) or CE marking.